These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 24929163

  • 1. Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.
    Atallah S, Cho BC, Allibhai Z, Taremi M, Giuliani M, Le LW, Brade A, Sun A, Bezjak A, Hope AJ.
    Int J Radiat Oncol Biol Phys; 2014 Jul 01; 89(3):532-8. PubMed ID: 24929163
    [Abstract] [Full Text] [Related]

  • 2. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1064-70. PubMed ID: 24210082
    [Abstract] [Full Text] [Related]

  • 3. Validating impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.
    Atallah S, Le LW, Bezjak A, MacRae R, Hope AJ, Pantarotto J.
    Thorac Cancer; 2021 Jan 01; 12(2):201-209. PubMed ID: 33258301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J, Kloecker G, Woo S, Dunlap NE.
    Am J Clin Oncol; 2016 Apr 01; 39(2):147-53. PubMed ID: 24457534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.
    Yamamoto T, Kadoya N, Shirata Y, Koto M, Sato K, Matsushita H, Sugawara T, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Ito K, Katagiri Y, Takeda K, Jingu K.
    Radiat Oncol; 2015 Feb 07; 10():35. PubMed ID: 25886315
    [Abstract] [Full Text] [Related]

  • 14. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
    Shaverdian N, Tenn S, Veruttipong D, Wang J, Hegde J, Lee C, Cao M, Agazaryan N, Steinberg M, Kupelian P, Lee P.
    Br J Radiol; 2016 Feb 07; 89(1059):20150963. PubMed ID: 26764282
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
    Marwaha G, Stephans KL, Woody NM, Reddy CA, Videtic GM.
    J Thorac Oncol; 2014 Nov 07; 9(11):1693-7. PubMed ID: 25185531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
    Liao ZX, Komaki RR, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):775-81. PubMed ID: 19515503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.